Rutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including complex robotic surgery, clinical trials and novel therapeutics such as precision medicine, CAR T-Cell Therapy and other forms of immunotherapy.
Exploring Novel Cell-Based Therapy in Non-Hodgkin Lymphoma
Investigators at Rutgers Cancer Institute of New Jersey have found that a treatment based on a novel cellular product programmed to deliver an overabundance of chimeric antigen receptor causes cell death in non-Hodgkin lymphoma models that are sensitive or resistant to standard therapies. Andrew M. Evens, DO, MSc, FACP, associate director for clinical services and director of the Lymphoma Program at Rutgers Cancer Institute and medical director of oncology services at RWJBarnabas Health, who is the senior and corresponding author of the work, shares more about the results published recently in the journal Leukemia. Learn more
February is Cancer Prevention Month
Cancer is the result of the uncontrolled growth and spread of abnormal cells within the body. Some of these abnormal cells can be discovered through a cancer screening. Preventative tests can lead to early detection of cancers, some of which if discovered early can be successfully treated. Resources available through Rutgers Cancer Institute of New Jersey and ScreenNJ describe risk factors and other information that can be useful in speaking to a health care provider about a screening schedule. Learn more
2020: The ‘Year of the Nurse’
Did you know? The World Health Assembly (an arm of the World Health Organization) has designated 2020 as the ‘International Year of the Nurse?’ Oncology nursing is a unique specialty that requires specific knowledge of the biological and psychosocial dimensions of cancer and its effects on individuals and families. At Rutgers Cancer Institute of New Jersey, nurses serve as critical members of multidisciplinary healthcare teams providing patient care and engaging in clinical research, patient education, nursing education, and advanced practice roles. Learn more
Our Shining Knight
It was a special honor for pediatric cancer survivor Hudson Yahara at a recent Rutgers men's basketball game, as he was recognized as the ‘Shining Knight of the Game.’ Treated for a rare and aggressive form of cancer with proton therapy at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital New Brunswick, an RWJBarnabas Health facility, Hudson was honored for his bravery and strength throughout his cancer journey. Learn more
